HRS4R
Vull donar

EDUARD ESTEVE LAFUENTE

Firma
EDUARD ESTEVE-LAFUENTE
Posició
Investigador/a Post-doctoral – R2
Investigadors/es Post-doctorals – R2

Publicacions

Vicens-Bordas J, Esteve E, Fort-Vanmeerhaeghe A, Casals M, Bandholm T, Ishøi L, Opar D, Shield A, Thorborg K

Performance changes during the off-season period in football players - Effects of age and previous hamstring injury.

JOURNAL OF SPORTS SCIENCES, 2020, 38, 2489-2499 dx.doi.org/10.1080/02640414.2020.1792160

Martín-Campos JM, Plana N, Figueras R, Ibarretxe D, Caixàs A, Esteve E, Pérez A, Bueno M, Mauri M, Roig R, Martínez S, Pintó X, Masana L, Julve J, Blanco-Vaca F, Xarxa d’Unitats de Lípids i Arteriosclerosi (XULA)

Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting.

J CLIN LIPIDOL, 2018, 12, 1452-1462 dx.doi.org/10.1016/j.jacl.2018.09.002

Sánchez-Hernández RM, Prieto-Matos P, Civeira F, Lafuente EE, Vargas MF, Real JT, Goicoechea FG, Fuentes FJ, Pocovi M, Boronat M, Wägner AM, Masana L

Autosomal recessive hypercholesterolemia in Spain.

Atherosclerosis, 2018, 269, 1-5 dx.doi.org/10.1016/j.atherosclerosis.2017.12.006

D'Erasmo L, Minicocci I, Nicolucci A, Pintus P, Roeters Van Lennep JE, Masana L, Mata P, Sánchez-Hernández RM, Prieto-Matos P, Real JT, Ascaso JF, Lafuente EE, Pocovi M, Fuentes FJ, Muntoni S, Bertolini S, Sirtori C, Calabresi L, Pavanello C, Averna M, Cefalu AB, Noto D, Pacifico AA, Pes GM, Harada-Shiba M, Manzato E, Zambon S, Zambon A, Vogt A, Scardapane M, Sjouke B, Fellin R, Arca M

Autosomal Recessive Hypercholesterolemia: Long-Term Cardiovascular Outcomes.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71, 279-288 dx.doi.org/10.1016/j.jacc.2017.11.028

Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernàndez-Real JM, Bäckhed F

Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.

NATURE MEDICINE, 2017, 23, 850-858 dx.doi.org/10.1038/nm.4345

Suárez-Ortegón MF, Moreno M, Arbeláez A, Xifra G, Mosquera M, Moreno-Navarrete JM, Aguilar-de Plata C, Esteve E, Ricart W, Fernández-Real JM

Circulating hepcidin in type 2 diabetes: A multivariate analysis and double blind evaluation of metformin effects.

MOLECULAR NUTRITION & FOOD RESEARCH, 2015, 59, 2460-2470 dx.doi.org/10.1002/mnfr.201500310

Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, Xifra G, Martínez C, Ricart W, Rieusset J, Rome S, Karczewska-Kupczewska M, Straczkowski M, Fernández-Real JM

Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization.

Diabetes Care, 2014, 37, 1375-1383 dx.doi.org/10.2337/dc13-1847

Esteve E, Ricart W, Fernández-Real JM

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2011, 14, 483-490 dx.doi.org/10.1097/MCO.0b013e328348c06d

Esteve E, Castro A, Moreno JM, Vendrell J, Ricart W, Fernández-Real JM

Circulating bactericidal/permeability-increasing protein (BPI) is associated with serum lipids and endothelial function

THROMBOSIS AND HAEMOSTASIS, 2010, 103, 780-787 dx.doi.org/10.1160/TH09-08-0596

Leal Y, Garcia-Gabin W, Bondia J, Esteve E, Ricart W, Fernández-Real JM, Vehí J

Enhanced algorithm for glucose estimation using the continuous glucose monitoring system.

Medical Science Monitor, 2010, 16, 51-58

Coneix l’IDIBGI!

menu